Anti-HER3 Monoclonal Antibody Inhibits Acquired Trastuzumab-Resistant Gynecologic Cancers.
about
HER3, but Not HER4, Plays an Essential Role in the Clinicopathology and Prognosis of Gastric Cancer: A Meta-AnalysisPreclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer.A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer.Co-expression and prognostic significance of the HER family members, EGFRvIII, c-MET, CD44 in patients with ovarian cancer.Association between the overexpression of Her3 and clinical pathology and prognosis of colorectal cancer: A meta-analysis
P2860
Anti-HER3 Monoclonal Antibody Inhibits Acquired Trastuzumab-Resistant Gynecologic Cancers.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Anti-HER3 Monoclonal Antibody ...... Resistant Gynecologic Cancers.
@en
type
label
Anti-HER3 Monoclonal Antibody ...... Resistant Gynecologic Cancers.
@en
prefLabel
Anti-HER3 Monoclonal Antibody ...... Resistant Gynecologic Cancers.
@en
P2093
P2860
P356
P1476
Anti-HER3 Monoclonal Antibody ...... Resistant Gynecologic Cancers.
@en
P2093
Beifen Shen
Chunxia Qiao
Jiannan Feng
Tingting Zhou
Xinying Li
Yanting Duan
P2860
P304
P356
10.1177/1533034615588422
P50
P577
2015-06-03T00:00:00Z